Literature DB >> 2620261

Involvement of endogenous galactoside-binding lectin of Xenopus laevis in pattern formation of Xenopus neurites in vitro.

N C Milos1, Y L Ma, Y N Frunchak.   

Abstract

Galactoside-binding lectin has been purified from Xenopus laevis embryos at the stage of neural crest migration. Addition of this lectin to neurite cultures correlates with the appearance of fascicles of greater diameter and shorter length compared with controls. Lectin-treated neurites are also more spread out on the substratum than their controls. The potent hapten inhibitor of the endogenous lectin, thiodigalactoside (TDG), was also added to these cultures. TDG-treated neurites are less well spread out than the controls; fascicle diameters and lengths are not altered. These results suggest that galactoside-bearing receptors and endogenous galactoside-binding lectin are present in these neurites and can participate in controlling neuronal morphogenesis in vitro, although to differing extents.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2620261     DOI: 10.1016/0922-3371(89)90005-1

Source DB:  PubMed          Journal:  Cell Differ Dev        ISSN: 0922-3371


  4 in total

1.  Localization of endogenous galactoside-binding lectin during morphogenesis of Xenopus laevis.

Authors:  N C Milos; Y L Ma; P V Varma; M P Bering; Z Mohamed; L M Pilarski; Y N Frunchak
Journal:  Anat Embryol (Berl)       Date:  1990

Review 2.  On the possible role of endogenous lectins in early animal development.

Authors:  S E Zalik
Journal:  Anat Embryol (Berl)       Date:  1991

3.  Changing complexity of endogenous lectin activities during juvenile development of Xenopus laevis.

Authors:  N C Milos; Y N Frunchak
Journal:  Rouxs Arch Dev Biol       Date:  1993-01

4.  Alterations of heart development in Xenopus laevis by galactoside-binding lectin or its sugar hapten inhibitor.

Authors:  Y N Frunchak; G N Martha; K D McFadden; N C Milos
Journal:  Anat Embryol (Berl)       Date:  1993-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.